<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41859">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01881724</url>
  </required_header>
  <id_info>
    <org_study_id>CUHK466711</org_study_id>
    <nct_id>NCT01881724</nct_id>
  </id_info>
  <brief_title>Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients</brief_title>
  <official_title>Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <authority>Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial with 12 month sleep education as intervention,
      followed by a 12 month observational period, to study whether sleep education would improve
      glycemic control and cardiometabolic profile of sleep deprived type 2 diabetic patients and
      evaluate the neurohormonal changes associated with sleep education.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be identified from the Diabetes Mellitus and Endocrine Centre of Prince of
      Wales Hospital and Yao Chung Kit Diabetes Assessment Centre, The Chinese University of Hong
      Kong. All participants will have diabetes complications screening and comphrensive
      evaluations for glycemic control and cardiometabolic risk factors.Eligible subjects will be
      randomized to 2 groups (usual or conventional care versus intervention with sleep education
      program) for 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in HbA1c from baseline</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>fasting plasma glucose</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin resistance</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>HOMA_IR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body weight</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipid profile</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sleep duration</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">264</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sleep education program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep education</intervention_name>
    <arm_group_label>sleep education program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 18-65 years

          2. Type 2 diabetes mellitus

          3. Chinese ethnicity

          4. Able and willing to give informed written consent

          5. Sleep deprived, defined as subjective sleeping time &lt;6 hours per day

        Exclusion Criteria:

          1. Type 1 diabetes mellitus

          2. Known history of psychiatric disorders (e.g. depression, anxiety, dementia)

          3. Sleep disorders secondary to another medical condition (e.g. obstructive sleep apnoea
             (OSA), circadian rhythm sleep disorder)

          4. Concomitant chronic medical condition that was likely to be the cause of sleep
             problem (e.g. benign prostatic hypertrophy, chronic pain)

          5. Concurrent use of hypnotic drugs, psychotic medications and any drugs that are known
             to affect sleep.

          6. Any condition, as judged by the investigators, as ineligible to participate in this
             study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alice PS Kong, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alice Kong, FRCP</last_name>
    <phone>(852)26323307</phone>
    <email>alicekong@cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tracy Cheng, RN</last_name>
    <phone>(852)26323663</phone>
    <email>tracycheng@cuhk.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <zip>Hong Kong</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Kong, FRCP</last_name>
      <phone>+852 2632 3307</phone>
      <email>alicekong@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Risa Ozaki, MRCP</last_name>
      <phone>+852 2632 3663</phone>
      <email>risaozaki@cuhk.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Risa Ozaki, MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>Hong Kong</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alice Kong, FRCP</last_name>
      <phone>(852)26323307</phone>
      <email>alicekong@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Tracy Cheng, RN</last_name>
      <phone>(852)26323663</phone>
      <email>tracycheng@cuhk.edu.hk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 19, 2013</lastchanged_date>
  <firstreceived_date>October 18, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Alice Pik Shan KONG</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
